Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Minoru Takada

Showing results (61-70 of 105) with videos related to

Pageof 11
Sort By:
The Oncologist|February 7, 2015
The role of smoking status on the progression-free survival of non-small cell lung cancer patients harboring activating epidermal growth factor receptor (EGFR) mutations receiving first-line EGFR tyrosine kinase inhibitor versus platinum doublet chemotherapy: a meta-analysis of prospective randomized trialsYoshikazu Hasegawa, Masahiko Ando, Makoto Maemondo, et al.
Lung Cancer (Amsterdam, Netherlands)|August 8, 2006
L858R EGFR mutation status correlated with clinico-pathological features of Japanese lung cancerHidefumi Sasaki, Katsuhiko Endo, Minoru Takada, et al.
Asian Journal of Endoscopic Surgery|March 14, 2022
Carbon dioxide embolism during transanal total mesorectal excision: A hint of prevention from a case reportMasakazu Fujii, Kentaro Kato, Chisato Ichimaru, et al.
Investigational New Drugs|February 28, 2006
Multicenter phase II study of amrubicin, 9-amino-anthracycline, in patients with advanced non-small-cell lung cancer (Study 1): West Japan Thoracic Oncology Group (WJTOG) trialToshiyuki Sawa, Takashi Yana, Minoru Takada, et al.
Frontiers in Immunology|January 23, 2023
Functional changes in cytotoxic CD8+ T-cell cross-reactivity against the SARS-CoV-2 Omicron variant after mRNA vaccinationTakuto Nogimori, Koichiro Suzuki, Yuji Masuta, et al.
Surgical Case Reports|June 16, 2018
Pathological complete response of locally advanced colon cancer after preoperative radiotherapy: a case report and narrative review of the literatureSho Sekiya, Kiyotaka Imamura, Shintaro Takeuchi, et al.
Trials|June 19, 2023
PYloroplasty versus No Intervention in GAstric REmnant REconstruction after Oesophagectomy: study protocol for the PYNI-GAREREO phase III randomized controlled trialNaoya Okada, Yoshihiro Kinoshita, Shoji Nishihara, et al.
Journal of Cancer Research and Clinical Oncology|May 15, 2008
A novel EGFR mutation D1012H and polymorphism at exon 25 in Japanese lung cancerHidefumi Sasaki, Katsuhiro Okuda, Minoru Takada, et al.
Clinical Lung Cancer|February 13, 2014
Early pharmacodynamic assessment using ¹⁸F-fluorodeoxyglucose positron-emission tomography on molecular targeted therapy and cytotoxic chemotherapy for clinical outcome predictionMasaki Kanazu, Kaoru Maruyama, Masahiko Ando, et al.
Lung Cancer (Amsterdam, Netherlands)|August 10, 2007
EGFR exon 20 insertion mutation in Japanese lung cancerHidefumi Sasaki, Katsuhiko Endo, Minoru Takada, et al.
Pageof 11

Showing results (61-70 of 105) with videos related to

Sort By:
Pageof 11
The Oncologist|February 7, 2015
The role of smoking status on the progression-free survival of non-small cell lung cancer patients harboring activating epidermal growth factor receptor (EGFR) mutations receiving first-line EGFR tyrosine kinase inhibitor versus platinum doublet chemotherapy: a meta-analysis of prospective randomized trialsYoshikazu Hasegawa, Masahiko Ando, Makoto Maemondo, et al.
Lung Cancer (Amsterdam, Netherlands)|August 8, 2006
L858R EGFR mutation status correlated with clinico-pathological features of Japanese lung cancerHidefumi Sasaki, Katsuhiko Endo, Minoru Takada, et al.
Asian Journal of Endoscopic Surgery|March 14, 2022
Carbon dioxide embolism during transanal total mesorectal excision: A hint of prevention from a case reportMasakazu Fujii, Kentaro Kato, Chisato Ichimaru, et al.
Investigational New Drugs|February 28, 2006
Multicenter phase II study of amrubicin, 9-amino-anthracycline, in patients with advanced non-small-cell lung cancer (Study 1): West Japan Thoracic Oncology Group (WJTOG) trialToshiyuki Sawa, Takashi Yana, Minoru Takada, et al.
Frontiers in Immunology|January 23, 2023
Functional changes in cytotoxic CD8+ T-cell cross-reactivity against the SARS-CoV-2 Omicron variant after mRNA vaccinationTakuto Nogimori, Koichiro Suzuki, Yuji Masuta, et al.
Surgical Case Reports|June 16, 2018
Pathological complete response of locally advanced colon cancer after preoperative radiotherapy: a case report and narrative review of the literatureSho Sekiya, Kiyotaka Imamura, Shintaro Takeuchi, et al.
Trials|June 19, 2023
PYloroplasty versus No Intervention in GAstric REmnant REconstruction after Oesophagectomy: study protocol for the PYNI-GAREREO phase III randomized controlled trialNaoya Okada, Yoshihiro Kinoshita, Shoji Nishihara, et al.
Journal of Cancer Research and Clinical Oncology|May 15, 2008
A novel EGFR mutation D1012H and polymorphism at exon 25 in Japanese lung cancerHidefumi Sasaki, Katsuhiro Okuda, Minoru Takada, et al.
Clinical Lung Cancer|February 13, 2014
Early pharmacodynamic assessment using ¹⁸F-fluorodeoxyglucose positron-emission tomography on molecular targeted therapy and cytotoxic chemotherapy for clinical outcome predictionMasaki Kanazu, Kaoru Maruyama, Masahiko Ando, et al.
Lung Cancer (Amsterdam, Netherlands)|August 10, 2007
EGFR exon 20 insertion mutation in Japanese lung cancerHidefumi Sasaki, Katsuhiko Endo, Minoru Takada, et al.
Pageof 11